Montirelin

DB19762ExperimentalSmall molecule

Montirelin is a small molecule drug. The usage of the INN stem '-tirelin' in the name indicates that Montirelin is a thyrotropin releasing hormone analogue. Montirelin has a monoisotopic molecular...

Mechanism: Pharmacologically active on Thyrotropin-releasing hormone receptor
Curator reviewed
Formula / weight: C₁₇H₂₄N₆O₄S · 408.48 g/mol (avg)
Code names: CG-3703 · CNK-602A

Resolves to

Compound

UNII30MUJ6YYUYCAS90243-66-6ChEBI31864

Structure

InChIKeyRSHMQGIMHQPMEB-IXOXFDKPSA-NSMILESC[C@H]1SC[C@H](NC1=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N1CCC[C@H]1C(N)=O

Targets

P34981TRHR

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Montirelin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account